You are here
Funding
New Funding Opportunities
Notice | Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) |
---|---|
Notice Number | PAR-20-165 |
Post Date | April 13, 2020 |
Expiration Date | March 6, 2023 |
Notice | Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
---|---|
Notice Number | PAR-20-168 |
Post Date | April 13, 2020 |
Expiration Date | May 8, 2023 |
Past Funding Opportunities
Notice | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54, Basic Experimental Studies Involving Humans Allowed) |
---|---|
Notice Number | RFA-NS-22-019 |
Notice | Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required) |
---|---|
Notice Number | RFA-NS-22-020 |
Notice | Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional) |
---|---|
Notice Number | PAR-18-664 |
Notice | Analytical Validation of a Candidate Biomarker for Neurological Disease (U01) (Clinical Trial Optional) |
---|---|
Notice Number | PAR-18-550 |
Notice | Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional) |
---|---|
Notice Number | PAR-18-549 |
Notice | Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional) |
---|---|
Notice Number | PAR-18-548 |
This page last reviewed on August 19, 2022